Mr. Speaker, it is my privilege to rise in the House and join my colleagues in the official opposition in opposing the bill. Normally I do not read a speech, but I find that it is very important on this bill to be clear that I am conveying the actual words of medical specialists, including those from my city of Edmonton, from the Canadian Medical Association, and from the Supreme Court of Canada.
In reintroducing Bill C-2, an act to amend the Controlled Drugs and Substances Act, the government is flying in the face of credible, strong evidence that safe injection sites lead to improvements in public health and public safety.
The specific objective of organized, supervised safe injection sites is widely recognized to improve health outcomes and to reduce impacts to communities where drug use is already occurring, and it is important to recognize that drug use is occurring.
Bill C-2, in imposing 24 conditions on the operation of any safe injection site and then completely giving the discretion to the minister to ignore that advice and impose her decision, rather than relying on the opinions of scientists and medical experts, has a clear intent of rendering it inoperative.
The intent of a safe injection program is to directly address the problem of addiction to dangerous and illegal substances by mitigating the negative effects of such addictions while ensuring that addicts have access to support when they are ready to begin treatment to get off drugs, and it is important to emphasize. That is clearly the path we support, and that is the path of the safe injection sites.
Safe injection sites have been proven to do both of these things. The Canadian Medical Association has expressed deep concern about this legislation. It has pointed out that there is overwhelming clinical evidence to show that safe injection sites save lives, and it has called for such facilities to be included in a national drug strategy. According to the CMA:
Supervised injection programs are an important harm reduction strategy. Harm reduction is a central pillar in a comprehensive public health approach to disease prevention and health promotion. In a preliminary assessment based on initial review of the Bill, the CMA is deeply concerned that the proposed legislation may be creating unnecessary obstacles and burdens that could ultimately deter creation of more injection sites.
The CMA's Dr. Haggie, then president, in response to the unanimous decision of the Supreme Court of Canada, said:
While for some this is an ideological issue, for physicians it's about the autonomy to make medical decisions based on evidence, and the evidence shows that supervised injection reduces the spread of infectious diseases and the incidence of overdose and death.
Dr. Stan Houston is a professor and specialist in infectious diseases at the University of Alberta, and he has extensive experience working with HIV patient care and organizations assisting such patients. Dr. Houston expressed support for the operation of safe injection sites for a number of important health-related reasons. According to Dr. Houston:
Although exact numbers are difficult to determine, hepatitis C infection rates run rampant through intravenous drug users. At one point, more than 80 per cent of those users were infected.
He has advised that due to needle exchanges and other social services provided by Streetworks, an Edmonton support program, the rates of HIV and hepatitis C have declined. According to Dr. Houston:
HIV cases are steadily going down in drug users in Edmonton. In fact that's our biggest HIV prevention success story. HIV rates are going up in other risk groups, but they are going down in injection drug users. And harm reduction practices should get a large part of the credit.
He said that by provision of a safe, supervised location for injection, staffed by medically qualified people, the probability of engaging drug users in drug treatment is substantially enhanced. He said that the preponderance of evidence from 25 peer-reviewed reports determines that programs such as InSite improve rates of further treatment for addictions.
Dr. Houston has advised me that, to his knowledge, not one case of drug overdose has occurred at InSite since 2003. That is a lot of lives saved, lives that can be redeemed and then supported to end addiction. Should that not be the health objective?
Dr. Houston has pointed out to me that those who operate safe injection sites are not pro drug use. It is quite the opposite. Surely it is better to have addicts injecting drugs in a clean, secure place instead of back alleys. Quite logically, it is a preferable alternative to ensure public safety. He has also called for more government funding of drug treatment facilities to help end their addictions.
Dr. Houston points out that the research supports his position. The obvious question, then, is this: why is the government not willing to take the advice of Canadian doctors when it comes to dealing with a serious health issue?
In September, a total of 87 organizations experienced at dealing with addictions signed a letter to the Minister of Health, urging her to not reintroduce this bill. They included a number of Edmonton organizations that assist the homeless, HIV-infected persons and addicted persons, such as the Boyle Street Community Services, the Bissell Centre, the George Spady Centre and Street Works. Their common request to the minister was for support for increased access to supervised consumption sites similar to the InSite program in Vancouver and those in other nations, including Switzerland, Germany and the Netherlands, in order that lives could be saved.
These dedicated and highly respected community organizations point out that supervised consumption sites have been proven to decrease overdose, death, injury, and risk behaviours associated with HIV and hepatitis C infections; to increase access to health care for marginalized people; to save health care costs; and to decrease open drug use and publicly discarded drug use equipment, which is one of the issues communities usually raise.
I urge the minister to respond to their request to sit down with them to learn from their direct experience in dealing, on a daily basis, with people battling addictions and seek effective solutions to both assist those addicted and increase public safety.
There are obvious medical, social and psychological costs associated with a single HIV infection. If nothing else, one can appreciate the cost savings derived from preventing HIV infection. Directly because of the introduction of a needle exchange program in Edmonton, reduced rates of infection among drug addicts have been reported for both HIV/AIDS and hepatitis C, while in the same period rates have increased in other high-risk areas.
If we are truly serious about tackling the issue of drug addiction and the attendant health risks to the entire Canadian population, as parliamentarians we have an obligation to base our decisions on appropriate program or regulatory responses, sound science, and research results. Surely this should be the basis for all good public policy.
As the Canadian HIV/AIDS Legal Network concluded from a detailed study, “many of the arguments against are ill-conceived or overstated, and are outweighed by the likely benefits of safe injection facilities”. It reports that there is an ethical imperative to at least support the trial facilities given the unacceptable harms currently experienced by drug users and the general community, and the potential for these sites to eliminate or reduce at least some of the harms. It advises that a refusal to establish these critical sites may be deemed to violate human rights obligations under international law or potentially subject governments to negligence suits. It is important to observe what they are advising us.
It is important to observe and respect as well the unanimous ruling of the Supreme Court of Canada in favour of the continued operation of InSite and right of access to similar facilities.
The Chief Justice of the Supreme Court stated in that unanimous decision:
Where, as here, a supervised injection site will decrease the risk of death and disease, and there is little or no evidence that it will have a negative impact on public safety, the Minister should generally grant an exemption.
In closing, by shutting its eyes to the evidence and seeking to put as many barriers in the way of communities opening their own safe consumption sites, the government is risking the lives and health of Canadians. Let us not forget that if it were not for the Supreme Court, lnSite would have been closed.
I urge the Minister of Health to withdraw this bill and begin a serious consultation on how we can decrease addiction to illegal drugs in Canada and the attendant health and social costs.